Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients

Yuichiro Yano, Masamitsu Nakazato, Koji Toshinai, Takashi Inokuchi, Shuntaro Matsuda, Toshiaki Hidaka, Manabu Hayakawa, Kenji Kangawa, Kazuyuki Shimada, Kazuomi Kario

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


BACKGROUND We aimed to assess the predictive value of circulating levels of des-acyl ghrelin, an abundant form of ghrelin in humans, for the risk of cardiovascular disease (CVD) in older hypertensive patients. We simultaneously evaluated other biomarkers, such as high-molecular-weight (HMW) adiponectin, high-sensitivity C-reactive protein (hs-CRP), and plasminogen activator inhibitor 1 (PAI-1), for their usefulness in risk prediction. METHODS We enrolled 590 older hypertensive patients (mean age = 72.9 years; 41.0% men). The incidences of CVD, including coronary artery disease, stroke, congestive heart failure, and sudden death, were prospectively ascertained. RESULTS During an average duration of 2.8 (SD = 0.7) years (1,653 person-years), there were 42 CVD events. Patients with CVD events had lower levels of des-acyl ghrelin at baseline than those without CVD events (median = 78.2 vs. 114.7fmol/ml; P < 0.001). No difference was found among other biomarkers between the patients with CVD events and those without such events. The Cox proportional hazards model adjusted by covariables revealed that the hazard ratio for CVD events in patients with a 1-SD decrease of log des-acyl ghrelin was 1.8 (95% confidence interval = 1.3-2.4). Incorporation of des-acyl ghrelin in the risk model (including age, current smoking, 24-hour systolic blood pressure, preexisting CVD, and carotid intima-media thickness) improved the C statistics (from 0.683 to 0.721; P = 0.22) and resulted in a net reclassification improvement of 20.5% (P = 0.02). In contrast, HMW adiponectin, hs-CRP, and PAI-1 provided no improvement in risk prediction. CONCLUSIONS Des-acyl ghrelin improved the prediction of CVD events in older hypertensive patients.

Original languageEnglish
Pages (from-to)727-733
Number of pages7
JournalAmerican Journal of Hypertension
Issue number5
StatePublished - 1 May 2014
Externally publishedYes


  • blood pressure
  • cardiovascular disease
  • des-acyl ghrelin
  • geriatric
  • hypertension.


Dive into the research topics of 'Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients'. Together they form a unique fingerprint.

Cite this